Shotblocker® Use in Subcutaneous Injection

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

June 5, 2018

Study Completion Date

November 29, 2018

Conditions
Chronic Spontaneous Urticaria
Interventions
DEVICE

ShotBlocker®

The injection area gripped with ShotBlocker®, released after the drug administration and then the ShotBlocker® was removed. After injection, light pressure was applied to the injection area with dry cotton.

DEVICE

Placebo group

The smooth surface (opposite side) of the ShotBlocker® was placed in the injection area just before administration by an experience registered nurse and the drug was injected by holding it on the skin surface during the injection. The process was managed by the researcher.

Trial Locations (1)

34668

University of Health Sciences, Istanbul

All Listed Sponsors
lead

Saglik Bilimleri Universitesi

OTHER

NCT04210323 - Shotblocker® Use in Subcutaneous Injection | Biotech Hunter | Biotech Hunter